382 related articles for article (PubMed ID: 32304080)
41. Circulating tumor cells in breast cancer.
Banys M; Müller V; Melcher C; Aktas B; Kasimir-Bauer S; Hagenbeck C; Hartkopf A; Fehm T
Clin Chim Acta; 2013 Aug; 423():39-45. PubMed ID: 23623805
[TBL] [Abstract][Full Text] [Related]
42. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.
Aceto N; Bardia A; Miyamoto DT; Donaldson MC; Wittner BS; Spencer JA; Yu M; Pely A; Engstrom A; Zhu H; Brannigan BW; Kapur R; Stott SL; Shioda T; Ramaswamy S; Ting DT; Lin CP; Toner M; Haber DA; Maheswaran S
Cell; 2014 Aug; 158(5):1110-1122. PubMed ID: 25171411
[TBL] [Abstract][Full Text] [Related]
43. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
[TBL] [Abstract][Full Text] [Related]
44. Circulating tumor cells: clinical validity and utility.
Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
[TBL] [Abstract][Full Text] [Related]
45. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
46. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
[TBL] [Abstract][Full Text] [Related]
47. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
48. Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions.
Schochter F; Friedl TWP; deGregorio A; Krause S; Huober J; Rack B; Janni W
Cells; 2019 Nov; 8(11):. PubMed ID: 31717458
[TBL] [Abstract][Full Text] [Related]
49. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors.
Cho EH; Wendel M; Luttgen M; Yoshioka C; Marrinucci D; Lazar D; Schram E; Nieva J; Bazhenova L; Morgan A; Ko AH; Korn WM; Kolatkar A; Bethel K; Kuhn P
Phys Biol; 2012 Feb; 9(1):016001. PubMed ID: 22306705
[TBL] [Abstract][Full Text] [Related]
50. Circulating Tumor Cell Clusters: United We Stand Divided We Fall.
Amintas S; Bedel A; Moreau-Gaudry F; Boutin J; Buscail L; Merlio JP; Vendrely V; Dabernat S; Buscail E
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290245
[TBL] [Abstract][Full Text] [Related]
51. Progress in circulating tumor cell capture and analysis: implications for cancer management.
Balic M; Lin H; Williams A; Datar RH; Cote RJ
Expert Rev Mol Diagn; 2012 Apr; 12(3):303-12. PubMed ID: 22468820
[TBL] [Abstract][Full Text] [Related]
52. Molecular profiling of single circulating tumor cells with diagnostic intention.
Polzer B; Medoro G; Pasch S; Fontana F; Zorzino L; Pestka A; Andergassen U; Meier-Stiegen F; Czyz ZT; Alberter B; Treitschke S; Schamberger T; Sergio M; Bregola G; Doffini A; Gianni S; Calanca A; Signorini G; Bolognesi C; Hartmann A; Fasching PA; Sandri MT; Rack B; Fehm T; Giorgini G; Manaresi N; Klein CA
EMBO Mol Med; 2014 Nov; 6(11):1371-86. PubMed ID: 25358515
[TBL] [Abstract][Full Text] [Related]
53. Circulating Tumor Cells in Breast Cancer Patients.
Hall C; Valad L; Lucci A
Crit Rev Oncog; 2016; 21(1-2):125-39. PubMed ID: 27481009
[TBL] [Abstract][Full Text] [Related]
54. Detection of circulating tumor cells by means of machine learning using Smart-Seq2 sequencing.
Pastuszak K; Sieczczyński M; Dzięgielewska M; Wolniak R; Drewnowska A; Korpal M; Zembrzuska L; Supernat A; Żaczek AJ
Sci Rep; 2024 May; 14(1):11057. PubMed ID: 38744942
[TBL] [Abstract][Full Text] [Related]
55. Clinical utility of circulating tumor cells: an update.
Vasseur A; Kiavue N; Bidard FC; Pierga JY; Cabel L
Mol Oncol; 2021 Jun; 15(6):1647-1666. PubMed ID: 33289351
[TBL] [Abstract][Full Text] [Related]
56. Stem-like features of cancer cells on their way to metastasis.
Gkountela S; Aceto N
Biol Direct; 2016 Jul; 11():33. PubMed ID: 27457474
[TBL] [Abstract][Full Text] [Related]
57. Breast Cancer Circulating Tumor Cells: Current Clinical Applications and Future Prospects.
Cani AK; Hayes DF
Clin Chem; 2024 Jan; 70(1):68-80. PubMed ID: 38175590
[TBL] [Abstract][Full Text] [Related]
58. Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.
Lianidou ES; Mavroudis D; Georgoulias V
Br J Cancer; 2013 Jun; 108(12):2426-32. PubMed ID: 23756869
[TBL] [Abstract][Full Text] [Related]
59. Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones.
Cayrefourcq L; Thomas F; Mazard T; Assenat E; Assou S; Alix-Panabières C
Mol Cancer; 2021 Feb; 20(1):30. PubMed ID: 33557844
[TBL] [Abstract][Full Text] [Related]
60. A physical sciences network characterization of circulating tumor cell aggregate transport.
King MR; Phillips KG; Mitrugno A; Lee TR; de Guillebon AM; Chandrasekaran S; McGuire MJ; Carr RT; Baker-Groberg SM; Rigg RA; Kolatkar A; Luttgen M; Bethel K; Kuhn P; Decuzzi P; McCarty OJ
Am J Physiol Cell Physiol; 2015 May; 308(10):C792-802. PubMed ID: 25788574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
